Skip to Content
Ocean surface on the Greenbutts company website

ABACEL

The company name now being adopted in the Greenbutts rebrand.

The ABACEL Rebrand

Done. I should say that we are rebranding and will be changing the name of the company to ABACEL and Greenbutts will remain the trademark name of our product lines for the tobacco and nicotine industry. We are moving into various industries to replace single use plastics in all compatible products. We can discuss more on the call.

Biomaterial Technology Since 2010

Greenbutts™is an impact-driven company making the elimination of single-use micro-plastics possible with proprietary biomaterial technology. We have developed a patented, 100% biodegradable and water dispersing cigarette filter for use in the global tobacco industry and beyond.

Our Commitments

Environmental

Environmental

A viable alternative to acetate filters. We manufacture our filters from only the finest natural materials

Social

Social

Establishing partnerships with social impact organizations that keep our planet clean and healthy.

Governance

Governance

Help bring real change by supporting legislative proposals to mandate an end to cellulose acetate filters

Leadership Team

  • Tadas Lisauskas

    Tadas Lisauskas

    Founder and CEO

    A graduate of International Business and Finance from California State University at Long Beach (CSULB). Tadas worked in finance as a research analyst for the Norwegian investment company Baltic Management in Vilnius, Lithuania. He later became marketing manager of Omnitel Telecom and VP for Grey Worldwide Baltics Advertising agency. Upon his return to the USA in 2002 and building multiple small businesses in San Diego, California, Tadas co-founded Greenbutts™ in 2010 with the purpose to find a viable solution to the widespread pollution caused by cigarette filters.

  • Luis Sanches

    Luis Sanches

    Chief Strategy Officer

    Senior Business Executive with more than 30 years of international, cross functional and cross-cultural experience, managing businesses and teams, supporting business growth and transformations across multiple geographies (Australasia, North and South America, East and Western Europe). Held several senior executive roles over his long-standing career within British American Tobacco (BAT) including the position of Group Head of Product Development in the United Kingdom, SVP Research & Development (R&D) in Reynolds American Inc. based in the USA and Vice President of KBP - Kentucky BioProcessing which is a world leader in developing and employing GMP processes to manufacture recombinant proteins using novel plant-based technology. Successfully led the development of novelty scientific knowledge and multi-category consumer lead product innovations.

  • Steven Alderman

    CFO

    [Biography to be supplied]

  • Paulius Jurgutis

    Paulius Jurgutis

    Director of Business Development

    Trained at University of Michigan in Biochemistry, previously Paulius was director of business development at Toronto based start-ups ACD/Labs and Pharma Algorithms in the digital chemistry/drug discovery space. He led key early relationships with clients such as Abbott, GSK, Pfizer. Big Data experience led him to co-found YC funded Infoharmoni, a real-time platform for visualization of Twitter. Joining Greenbutts™ in 2019, he manages R&D/production and key clients as well as relationships with global NGO's concerned with SUP and Ocean pollution.

  • Jeff Noah

    Jeff Noah

    Director of Sales

    Jeff has worn many hats over the years from metal fabrication to machining, engineering, design and integration of making and packaging equipment for several industries. Jeff was co-founder and co-owner of Midwest tobacco Tube Inc. He build MTT from the ground up in 2007. At that time there were no cigarette tube factories left in the USA. Jeff sourced the equipment and set up the operations to create brands and in 2010 he obtained FDA approvals to become the premier tube company in the USA. Jeff joined Greenbutts™ as Director of Sales in 2020

Advisory Team

  • Peter Dobson

    Peter Dobson

    Advisor

    Is an exceptional sensory assessment expert with a 34 years craftsmanship & business leadership from farmer to consumer. In his recent role as Global Product Manager at British American Tobacco he managed key global drive brands as Dunhill and Pall Mall and he is internationally recognized as sensory "Guru".

    With his passion about consumer experience, he brings to Greenbutts a vast experience in combustible & OTP which will enhance the Greenbutts product portfolio offers and global consumer proposition relevance.

  • Vera Chetty PhD.

    Vera Chetty PhD.

    Lead Project Scientist

    Now Chief Scientist for NIRI, Vera attained a Masters Degree in Textile Engineering and PhD in Computer Simulation of Wetting and Wicking Phenomena at the Technical University of Liberec, Czech Republic. Vera has many years of experience in research and development of nonwoven and technical textiles which she gained by working for numerous research institutions in several different countries. Vera's main interest is in the development of novel nonwoven products.

  • Peter Kampian

    Peter Kampian

    Director

    Chief Restructuring Officer for PharmHouse Inc. and Muskoka Grown Limited

    Chief Financial Officer of Algonquin Income Fund Algonquin Power and Utilities Corp -TSX-AQN)

    Chief Financial Officer of Mettrum Health Corp., that was acquired by Canopy Growth Corporation in early 2017 for $430 million Canadian Chartered Accountant (CPA, CA), a member of the Institute of Corporate Directors, ICD.D designation for directors Business graduate of Wilfred Laurier University

  • Dan Kriznic

    Dan Kriznic

    Advisor

    High Standard Capital was founded by Dan Kriznic as an M&A advisory firm specializing in venture companies with unique intellectual property. To date the firm has been involved in over $500 million in transactions with a strong focus on big tobacco.

    More recently the firm sold Poda Holdings Inc, a publicly listed company, to Altria Group for $100.5 million USD and was instrumental in identifying the target, negotiating and closing the transaction. As part of the transaction, inventor and entrepreneur Ryan Selby, co-founder of PODA, joined the firm to assist in assessing unique intellectual property for the big tobacco space.

Subscribe for Updates

Receive company news releases and updates.

Signup is unavailable in this preview.